Health

VaxGen fails to meet deadlines and loses $900 million deal with the U.S. And, it's not just the vaccine that's in trouble but the whole bio-defense program it's part of, Project Bioshield. Helen Palmer reports.

Private companies aren't the only ones putting pressure on drugmakers to lower prescription prices. This morning the Bush administration will offer its own proposal. Dan Grech reports.

There's already a safety warning for children, but today an FDA panel looks at whether labeling on antidepressants should include increased risk of suicide for adults too. Helen Palmer reports.

Do cardiac stents help keep clogged arteries open in the long run? Kai Ryssdal talks with Heather Won Tesoreiro of the Wall Street Journal about today's recommendation by an FDA panel.

The U.S. will spend around $2 trillion on health care this year. And, Helen Palmer discovers, nearly a third of that cash is devoted to hospitals.

Researchers have almost definitively debunked the rumored link between cell phone use and cancer. Janet Babin has details.

Drug-coated stents used to prop open clogged arteries have some big advantages, but studies suggest they could carry dangerous risks too. Helen Palmer reports.

Employers can't afford the healthcare system we've got. Government can't fix it. And commentator Newt Gingrich says the solution actually rests in the American people.

A handful of private companies are set to provide employees with their own portable electronic medical records. Many workers welcome the convenience, but privacy advocates worry their information could be misused. Dan Grech reports.

Consumer Reports cautions today that a large percentage of chicken sold in the U.S. contains illness-causing bacteria. Critics say the report is flawed. John Dimsdale has details.